WallStreetZenWallStreetZen

NASDAQ: BWAY
Brainsway Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Brainsway earnings were $8.8M for the trailing 12 months ending Mar 31, 2026, with 91.7% growth year over year. The latest BWAY earnings report on Mar 31, 2026 announced Q1 2026 earnings of $2.3M, down 20.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BWAY reported annual earnings of $7.6M, with 159.3% growth. The next BWAY earnings date is Aug 12, 2026.

BWAY past earnings growth

How has BWAY's earnings growth performed historically?

Company
91.67%
Industry
6.46%
Market
87.11%
BWAY's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
BWAY's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
BWAY's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

BWAY earnings history

Current Revenue
$56.2M
Current Earnings
$8.8M
Current Profit Margin
15.6%

BWAY Return on Equity

Current Company
12.2%
Current Industry
6.5%
Current Market
13.5%
BWAY's Return on Equity (12.2%)... subscribe to Premium to read more.
High Return on Equity Performance

BWAY Return on Assets

Current Company
7.7%
Current Industry
5.8%
BWAY is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BWAY announces earnings.

BWAY Return on Capital Employed

Current Company
11.56%
Current Industry
9.4%
BWAY has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BWAY vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BWAY$12.41M$8.76M+91.67%$0.23
CERS$3.07M-$9.55MN/A-$0.05
CTKB-$24.55M-$74.00MN/A-$0.57
TCMD$41.71M$20.30M-14.24%$0.89
NPCE-$12.74M-$21.57MN/A-$0.65
View Top Medical Device Stocks

BWAY earnings dates

Next earnings date
Aug 12, 2026

Brainsway Earnings Reports & History FAQ

What were Brainsway's earnings last quarter?

Brainsway (NASDAQ: BWAY) reported Q1 2026 earnings per share (EPS) of $0.06, up 100% year over year. Total BWAY earnings for the quarter were $2.29 million. In the same quarter last year, Brainsway's earnings per share (EPS) was $0.03.

If you're new to stock investing, here's how to buy Brainsway stock.

When does Brainsway report earnings?

The next BWAY earnings date is Invalid Date. Add BWAY to your watchlist to be reminded of Brainsway's next earnings date.

Is Brainsway profitable or losing money?

As of the last Brainsway earnings report, Brainsway is currently profitable. Brainsway's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $8.76 million, a 123.59% increase year over year.

What was BWAY's earnings growth in the past year?

As of Brainsway's earnings date in Q3 2026, Brainsway's earnings has grown 91.67% year over year. This is 85.2 percentage points higher than the US Medical Devices industry earnings growth rate of 6.46%. BWAY earnings in the past year totalled $8.76 million.

What are Brainsway's earnings expectations?

The current EPS estimate for Brainsway's earnings report in Invalid Date is $0.10.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.